Table 3.
10-year ASCVD Risk* | Men < 40 years (non-smokers,
non-hypertensive) N=1,365 |
Women <50 years (non-smokers,
non-hypertensive) N=3,281 |
---|---|---|
<0.1% | 2.2% (1.5%–3.4%) | 7.7% (6.8%–8.8%) |
0.1% – 0.49% | 44.9% (41.9%–48.0%) | 58.7% (56.3%–61.1%) |
0.5% – 0.99% | 27.3% (24.8%–29.9%) | 23.3% (21.3%–25.4%) |
1.0% – 2.4% | 23.3% (20.6%–25.9%) | 10.0% (8.6%–11.6%) |
2.5% – 4.9% | 2.2% (1.6%–3.2%) | 0.2% (0.1%–0.5%) |
5.0% – 7.4% | 0.09% (0.02%–0.4%) | 0.04% (0.0%–0.3%) |
Brackets show 95% confidence intervals for that subgroup.
Risk calculated using 2013 ACC/AHA Sex and Race specific Pooled Cohort Equations. Low-prevalence subgroups defined as those subgroups in which we could rule out a prevalence of elevated cardiovascular risk (10-year ASCVD risk >5%) of more than 1%; and included non-smoking, non-hypertensive men under age of 40 years and non-smoking, non-hypertensive women under age of 50 years.